JPRN-UMIN000032717已完成未知
sefulness of Add-on Therapy of Pegylated Interferon alfa2a with Nucleoside/nucleotide Analog Treatment for Patients with Hepatitis B Virus Infection - Add-on therapy of PegIFN-alfa2a with NA treatment
Saitama Medical University, Department of Gastroenterology & Hepatology0 个研究点目标入组 26 人开始时间: 2018年5月25日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 26
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Cirrhosis HCC During pregnancy Mental illness merger Minor
研究者
相似试验
招募中
不适用
Effect of combination therapy of Pegylated interferon- Alpha 2a, Sofosbuvir and Ribavirin for 12 weeks versus combination of Sofosbuvir and Ribavirin for 24 weeks on viral loads in HCV Genotype 3 chronic hepatitis & compensated cirrhosis patientsHCV genotype 3 related chronic hepatitis & compensated cirrhosisSLCTR/2017/007Department of Hepatology Bangabandhu Sheikh Mujib Medical University
进行中（未招募）
不适用
add-on therapy of HBV chronic infectioChronic hepatitis BEUCTR2014-000815-15-ITAzienda Ospedaliera, Polo Universitario Luigi Sacco, Milano40
进行中（未招募）
1 期
Efficacy and safety of pegylated-proline-interferon alpha 2B (AOP2014) in maintaining deep molecular remissions in patients with chronic myeloid leukemia who discontinue ABL-kinase inhibitory therapy, with post-study follow-up.Chronic myeloid leukemiaMedDRA version: 21.0Level: LLTClassification code 10009016Term: Chronic myeloid leukemia in remissionSystem Organ Class: 100000004864EUCTR2016-001030-94-DEPhilipps University Marburg210
进行中（未招募）
1 期
Efficacy and safety of pegylated-proline-interferon alpha 2B (AOP2014) in maintaining deep molecular remissions in patients with chronic myeloid leukemia who discontinue ABL-kinase inhibitory therapy, with post-study follow-up.EUCTR2016-001030-94-FRPhilipps University Marburg214
招募中
不适用
Therapeutic effect of Peg-IFN therapy combined with RBV and simeprevir(SMV) on patients with chronic hepatitis C - a multicenter studyChronic hepatitis CJPRN-UMIN000013749Division of digestive and lifestyle disease, Kagoshima university graduate school of medical and dental sciences300